CRVS
Corvus Pharmacet (CRVS)
NASDAQ
$12.91+$0.28 (+2.22%)
Price as of Jun 24, 2026 4:05 AM EDT
  • $1.1B
    Market Cap
  • 191.01%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 27
Valuation
CRVS
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 64
Valuation
CRVS
vs History
vs S&P 500
3-Month Momentum
-7.17%
12-Month Momentum
250.67%
3-Month Risk Adjusted Momentum
-19.59%
12-Month Risk Adjusted Momentum
139.36%

True Yield

N/A
Valuation
CRVS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 34
Valuation
CRVS
vs History
vs S&P 500
Ohlson's O-Score
2